DVA

DaVita

Stock NYSE – Stock Market Prices, News & Analysis

DaVita Inc is a company specializing in dialysis services and other associated healthcare services for patients suffering from chronic kidney failure.

$ 154.81
2.15 %

DaVita

$ 154.81
2.15 %
DVA

DaVita Inc is a company specializing in dialysis services and other associated healthcare services for patients suffering from chronic kidney failure.

Price history of DaVita
Price history of DaVita

Performance & Momentum

6 Months 12.44 %
1 Year 7.75 %
3 Years 88.58 %
5 Years 39.47 %
Momentum
79

Strategic Analysis

DaVita • 2026

DaVita Inc positions itself as a major player in dialysis services for patients with chronic kidney failure in the United States, leveraging its specialized expertise and extensive network. Its model is based on providing essential long-term care, ensuring visibility of recurring revenues in a stable and growing healthcare sector.

Strengths
  • Dominant position in a niche market with high entry barriers
  • Economic model supported by inescapable demand related to chronic kidney conditions
  • Strong growth history backed by recognized clinical and operational expertise
Weaknesses
  • Significant reliance on the American reimbursement system and health regulations
  • Sensitivity to regulatory pressures and pricing evolution
Momentum

The positive momentum reflects moderate market confidence, supported by stable performance over several years despite a complex regulatory environment in the sector. This dynamic indicates strategic resilience and an appreciated adaptability among investors.

Analysis performed 1 week ago

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone